Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G G Turpie

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|May 15, 2009
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Ganesan Karthikeyan, John W Eikelboom, Alexander G G Turpie, et al.
BMJ (Clinical Research Ed.)|October 26, 2002
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategiesAlexander G G Turpie, Bernard S P Chin, Gregory Y H Lip
BMJ (Clinical Research Ed.)|October 19, 2002
Venous thromboembolism: pathophysiology, clinical features, and preventionAlexander G G Turpie, Bernard S P Chin, Gregory Y H Lip
Thrombosis and Haemostasis|September 28, 2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitorAlexander G G Turpie, Reinhold Kreutz, Juan Llau, et al.
Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
The Journal of the American Academy of Orthopaedic Surgeons|December 24, 2004
FondaparinuxAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2009
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patientsAlexander G G Turpie, Anthonie W A Lensing, Takeshi Fuji, et al.
The American Journal of Medicine|March 13, 2018
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous ThromboembolismCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
The Journal of Arthroplasty|February 1, 2006
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgeryClifford W Colwell, Lewis M Kwong, Alexander G G Turpie, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|May 15, 2009
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Ganesan Karthikeyan, John W Eikelboom, Alexander G G Turpie, et al.
BMJ (Clinical Research Ed.)|October 26, 2002
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategiesAlexander G G Turpie, Bernard S P Chin, Gregory Y H Lip
BMJ (Clinical Research Ed.)|October 19, 2002
Venous thromboembolism: pathophysiology, clinical features, and preventionAlexander G G Turpie, Bernard S P Chin, Gregory Y H Lip
Thrombosis and Haemostasis|September 28, 2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitorAlexander G G Turpie, Reinhold Kreutz, Juan Llau, et al.
Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
The Journal of the American Academy of Orthopaedic Surgeons|December 24, 2004
FondaparinuxAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2009
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patientsAlexander G G Turpie, Anthonie W A Lensing, Takeshi Fuji, et al.
The American Journal of Medicine|March 13, 2018
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous ThromboembolismCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
The Journal of Arthroplasty|February 1, 2006
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgeryClifford W Colwell, Lewis M Kwong, Alexander G G Turpie, et al.
Pageof 18